Диссертация (1174185), страница 36
Текст из файла (страница 36)
– 2011 – Т.3. №1. C.108-110.124. Собенин И.А., Сазонова М..А., Постнов А.Ю., Орехов А.Н. Патентнаязаявкаот10.08.2010«Способгенетическойдиагностикипредрасположенности к атеросклерозу», регистрационный № 2010133468.125. Собенин И.А., Сазонова М.А., ПостновА.Ю.,Бобрышев Ю.В.,Романенко Е.Б., Орехов А.Н. Патентная заявка от 09.10.2012. «Способгенодиагностики сердечно-сосудистых заболеваний», регистрационный№ 2012142947.288126. Струков А.И. Некоторые вопросы изучения об ишемической болезнисердца. // Кардиология. – 1973. – Т.10. – С.5-17.127. Султаналиев А.Н., Жданов В.С. Липоидоз интимы коронарных артерийсердца у новорожденных и детей первого года жизни.
// Арх. пат. – 1985. –Т.47. №10. – С.36-42.128. Сумароков А.Б., Панкратова В.Н., Лякишев А.А., Авдеева И.Ю. ИзучениеChlamydia pneumoniae при атеросклерозе. // Клин. Мед. – 1999. №10. C.47.129. Сухоруков В.С. Нарушения клеточной энергетики // Московский НИИпедиатрии и детской хирургии Минздрава РФ, 2002.130. Чазов Е.И.
Болезни сердца и сосудов. Руководство для врачей// М.:Медицина, 1992. 1 т. 496 с., 2 т. 512 с., 3 т. 448 с., 4 т. 448 с.131.Abd El-Aziz T.A., Hussein Y.M., Mohamed R.H., Shalaby S.M. Renin-angiotensin system genes polymorphism in Egyptians with premature coronaryartery disease. // Gene. 2012. V.498. Issue 2. P.270-275.132.Agaton C., Unneberg P., Sievertzon M.
, Holmberg A., Ehn M., Larsson M.,Odeberg J., Uhlén M., Lundeberg J. Gene expression analysis by signaturepyrosequencing. // Gene. 2002. May 1; V.289. Issue 1(2). P.31-39.133.Al-Fakhri N., Wilhelm J., Hahn M., Heidt M., Hehrlein F.W., Endisch A.M.,Hupp T., Cherian S.M., Bobryshev Y.V., Lord R.S., Katz N.
Increased expressionof disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulationof integrins alpha5beta1 and alphavbeta3 in atherosclerosis. // J. Cell. Biochem. –2003. V.89. Issue 4. P.808-823.134.Aleksova A, Di Nucci M, Gobbo M, Bevilacqua E, Pradella P, Salam K,Barbati G, De Luca A, Mascaretti L, Sinagra G. Factor-V HR2 haplotype andthromboembolic disease.
// ActaCardiol. 2015. Dec.; V.70. Issue 6. – P.707711. doi:10.2143/AC.70.6.3120184.135.Alizadeh Dehnavi R., de Roos A., Rabelink T.J., van Pelt J., Wensink M.J.,Romijn J.A., Tamsma J.T. Elevated CRP levels are associated with increased289carotid atherosclerosis independent of visceral obesity. // Atherosclerosis. – 2008. V.200. Issue 2. P.417-423.136.Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., FutcherA.B., Greider C.W., Harley C.B.
Telomere length predicts replicative capacity ofhuman fibroblasts. // Proc. Natl. Acad. Sci. USA. 1992. V.89. P.1011410118.137.Amato M., Veglia F., de Faire U., Giral P., Rauramaa R., Smit A.J., Kurl S.,Ravani A., Frigerio B., Sansaro D., Bonomi A., Tedesco C.C., Castelnuovo S.,Mannarino E., Humphries S.E., Hamsten A., Tremoli E., Baldassarre D.;IMPROVE study group. Carotid plaque-thickness and common carotid IMT showadditivevalueincardiovascularriskpredictionandreclassification.//Atherosclerosis.
– 2017. – Aug.; 263. – P.412-419.doi: 10.1016/j.atherosclerosis.2017.05.023.138.Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R.,Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., SmithA.J., Staden R., Young I.G. Sequence and organization of the humanmitochondrial genome. // Nature. 1981. V.290. Issue 5806. P.457-465.139.Andreassi M.G. Coronary atherosclerosis and somatic mutations: anoverview of the contributive factors for oxidative DNA damage.
// Mutat. Res. 2003. Jan.; V.543. Issue 1 P.67-86. Review.140.Andreassi M.G., Botto N., Colombo M.G., Biagini A., Clerico A. Geneticinstability and atherosclerosis: can somatic mutations account for the developmentof cardiovascular diseases? // Environ. Mol. Mutagen. 2000. V.35. Issue 4. –P.265-269.
Review.141. Andreu A.L., Bruno C., Shanske S., Shtilbans A., Hirano M., Krishna S.,Hayward L., Systrom D.S., Brown R.H. Jr., DiMauro S. Missense mutation in themtDNA cytochrome B gene in a patient with myopathy. // Neurology. 1998. V.51. Issue 5. P.1444-1447.290142. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M.,Howell N. Reanalysis and revision of the Cambridge reference sequence forhuman mitochondrial DNA.
// Nat. Genet. 1999. – Oct.; V.23. Issue 2. –P.147.143.Arai H., Hiro T., Kimura T., Morimoto T., Miyauchi K., Nakagawa Y.,Yamagishi M., Ozaki Y., Kimura K., Saito S., Yamaguchi T., Daida H.,Matsuzaki M. More intensive lipid lowering is associated with regression ofcoronary atherosclerosis in diabetic patients with acute coronary syndrome-subanalysis of JAPAN-ACS study. // J. Atheroscler.
Thromb. 2010. V.17. Issue10. P.1096-1107.144.Araujo V.P., Aguiar-Oliveira M.H., Oliveira J.L., Rocha H.M., OliveiraC.R., Rodrigues T.M., Nunes M.A., Britto I.M., Ximenes R., Barreto-Filho J.A.,Meneguz-Moreno R.A., Pereira R.M., Valença E.H., Oliveira-Neto L.A., VicenteT.A., Blackford A., Salvatori R. Arrest of atherosclerosis progression afterinterruption of GH replacement in adults with congenital isolated GH deficiency.// Eur. J. Endocrinol. 2012. V.166. Issue 6.
P.977-982.145.Arbustini E., Fasani R., Morbini P., Diegoli M., Grasso M., Dal Bello B.,Marangoni E., Banfi P., Banchieri N., Bellini O., Comi G., Narula J., Campana C.,Gavazzi A., Danesino C., Viganò M. Coexistence of mitochondrial DNA and betamyosin heavy chain mutations in hypertrophic cardiomyopathy with latecongestive heart failure. // Heart. 1998. V.80.
Issue 6. P.548-558.146.Arvanitis D.A., Flouris G.A., Spandidos D.A. Genomic rearrangements onVCAM1, SELE, APEG1and AIF1 loci in atherosclerosis. // J. Cell. Mol. Med. 2005. V.9. Issue 1. P.153-159.147.Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T.,Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitorendothelial cells for angiogenesis. // Science. 1997.
V.275. Issue 5302. P.964-967.291148.Aschoff L. Atherosclerosis, in lectures on pathology. // Hoeber. N.Y. 1924. P.131-153149.Asif A.R., Hecker M., Cattaruzza M.. Disinhibition of SOD-2 expression tocompensate for a genetically determined NO deficit in endothelial cells-briefreport. // Arterioscler. Thromb. Vasc. Biol.
2009. V.29. Issue 11. P.18901893.150.Aviv A., Chen W., Gardner J.P., Kimura M, Brimacombe M., Cao X.,Srinivasan S.R., Berenson G.S. Leukocyte telomere dynamics: longitudinalfindings among young adults in the Bogalusa Heart Study. // Am. J. Epidemiol. 2009. V.169. P.323-329.151.Babaya N., Ikegami H., Fujisawa T., Nojima K., Itoi-Babaya M., Inoue K.,Nakura J., Abe M., Yamamoto M., Jin J.J., Wu Z., Miki T., Fukuda M., OgiharaT. Association of I27L polymorphism of hepatocyte nuclear factor-1 alpha genewith high-density lipoprotein cholesterol level. // J.
Clin. Endocrinol. Metab. 2003. V.88. Issue 6. P.2548-2551.152.Bacci S., Rizza S., Prudente S., Spoto B., Powers C., Facciorusso A., PacilliA., Lauro D., Testa A., Zhang Y.Y., Di Stolfo G., Mallamaci F., Tripepi G., XuR., Mangiacotti D., Aucella F., Lauro R., Gervino E.V., Hauser T.H., Copetti M.,De Cosmo S,. Pellegrini F., Zoccali C., Federici M., Doria A., Trischitta V. TheENPP1 Q121 variant predicts major cardiovascular events in high-riskindividuals: evidence for interaction with obesity in diabetic patients.
// Diabetes. 2011. V.60. Issue 3. P.1000-1007.153.Bachen E.A., Muldoon M.F., Matthews K.A., Manuck S.B. Effects ofhemoconcentration and sympathetic activation on serum lipid responses to briefmental stress. // Psychosom. Med. 2002. V.64. Issue 4. P.587-594.154.Bai R.K., Wong L.J. Detection and quantification of heteroplasmic mutantmitochondrial DNA by real-time amplification refractory mutation systemquantitative PCR analysis: a single-step approach.//Clin.Chem. 2004. Jun.;V.50.
Issue 6. P.996-1001.292155.Baldassarre D., Castelnuovo S., Frigerio B., Amato M., Werba J.P., De JongA., Ravani A.L., Tremoli E., Sirtori C.R. Effects of timing and extent of smoking,type of cigarettes, and concomitant risk factors on the association betweensmoking and subclinical atherosclerosis. // Stroke. 2009. V.40. Issue 6. P.1991-1998.156.Ballinger S.W., Shoffner J.M., Hedaya E.V., Trounce I., Polak M.A.,Koontz D.A., Wallace D.C. Maternally transmitted diabetes and deafnessassociated with a 10.4 kb mitochondrial DNA deletion.
// Nat. Genet. – 1992.V.40. Issue 1 (1). P.11-15.157.Bang O.Y., Saver J.L., Liebeskind D.S., Lee P.H., Sheen S.S., Yoon S.R.,Yun S.W., Kim G.M., Chung C.S., Lee K.H., Ovbiagele B. Age-distinctpredictors of symptomatic cervicocephalic atherosclerosis. // Cerebrovasc. Dis. 2009. V.27. Issue 1. P.13-21.158.Bannwarth S., Procaccio V., Paquis-Flucklinger V. Surveyort Nuclease: ANew Strategy for a Rapid Identification of Heteroplasmic Mitochondrial DNAMutations in Patients With Respiratory Chain Defects.
// Hum. Mutat. 2005. V.25. P.575-582.159. Baracca A., Barogi S., Carelli V., Lenaz G., Solaini G. Catalytic activities ofmitochondrial ATP synthase in patients with mitochondrial DNA T8993Gmutation in the ATPase 6 gene encoding subunit a. // J. Biol. Chem. 2000. Feb.11; V.275. Issue 6. P.4177-4182.160.
Barinova V.A., Sazonova M.A., Sinyov V.V., Ryzhkova A.I., Zhelankin A.V.,Mitrofanov K.Y., Postnov A.Y., Orekhov A.N., Sobenin I.A. Association ofmitochondrial mutation T3336C with lipofibrous plaques in human aortic intima.//Atherosclerosis. – 2015. – V.241. – Issue 1. – e228-e229.doi: http://dx.doi.org/10.1016/j.atherosclerosis.2015.04.1064161.Barlovic D.P., Soro-Paavonen A., Jandeleit-Dahm K.A. RAGE biology,atherosclerosis and diabetes.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
